Immunization of cottontop tamarins and rabbits with a candidate vaccine against the Epstein-Barr virus based on the major viral envelope glycoprotein gp340 and alum
- 31 December 1994
- Vol. 12 (13) , 1180-1184
- https://doi.org/10.1016/0264-410x(94)90240-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vectorJournal of General Virology, 1992
- Immunological adjuvants: a role for liposomesImmunology Today, 1990
- Validation of a first‐generation epstein‐barr virus vaccine preparation suitable for human useJournal of Medical Virology, 1989
- Expression of Epstein-Barr Virus Membrane Antigen gp340/220 in Mouse Fibroblasts Using a Bovine Papillomavirus VectorJournal of General Virology, 1989
- Vero cell‐expressed Epstein‐Barr virus (EBV) gp350/220 protects marmosets from EBV challengeJournal of Medical Virology, 1989
- Recombinant vaccinia virus expressing epstein‐barr virus glycoprotein gp340 protects cottontop tamarins against EB virus‐induced malignant lymphomasJournal of Medical Virology, 1988
- The ISCOM: an immunostimulating complexImmunology Today, 1987
- Protection of cottontop tamarins against Epstein–Barr virus-induced malignant lymphoma by a prototype subunit vaccineNature, 1985
- Individual Tumors of Multifocal EB Virus-Induced Malignant Lymphomas in Tamarins Arise from Different B-Cell ClonesScience, 1985
- EB virus‐associated antibodies in caucasian patients with carcinoma OE the nasopharynx and in long‐term survivors after treatmentInternational Journal of Cancer, 1974